GLP-1 receptor agonists and inflammatory pathway modulation: Dual targeting of metabolic and immune dysfunction in insulin resistance. Ngabea MA, Dimeji IY. Biochem Biophys Res Commun 2025;789:152822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ngabea MA, Dimeji IY. GLP-1 receptor agonists and inflammatory pathway modulation: Dual targeting of metabolic and immune dysfunction in insulin resistance. Biochem Biophys Res Commun 2025;789:152822.
PMID: 41161090